LU90939I2 - 3-Methtylamino-6carboxamido-1,2,3,4-tetrahhydrocarbazole (frovatriptan) et ses sels solvates et hydrates - Google Patents

3-Methtylamino-6carboxamido-1,2,3,4-tetrahhydrocarbazole (frovatriptan) et ses sels solvates et hydrates

Info

Publication number
LU90939I2
LU90939I2 LU90939C LU90939C LU90939I2 LU 90939 I2 LU90939 I2 LU 90939I2 LU 90939 C LU90939 C LU 90939C LU 90939 C LU90939 C LU 90939C LU 90939 I2 LU90939 I2 LU 90939I2
Authority
LU
Luxembourg
Prior art keywords
tetrahhydrocarbazole
methtylamino
frovatriptan
solvate
hydrate salts
Prior art date
Application number
LU90939C
Other languages
English (en)
French (fr)
Original Assignee
Vernalis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10697363&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LU90939(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vernalis Ltd filed Critical Vernalis Ltd
Publication of LU90939I2 publication Critical patent/LU90939I2/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
LU90939C 1991-06-26 2002-07-24 3-Methtylamino-6carboxamido-1,2,3,4-tetrahhydrocarbazole (frovatriptan) et ses sels solvates et hydrates LU90939I2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919113802A GB9113802D0 (en) 1991-06-26 1991-06-26 Medicaments
PCT/GB1992/001082 WO1993000086A1 (en) 1991-06-26 1992-06-17 Use of tetrahydrocarbazone derivatives as 5ht1 receptor agonists

Publications (1)

Publication Number Publication Date
LU90939I2 true LU90939I2 (fr) 2002-09-24

Family

ID=10697363

Family Applications (1)

Application Number Title Priority Date Filing Date
LU90939C LU90939I2 (fr) 1991-06-26 2002-07-24 3-Methtylamino-6carboxamido-1,2,3,4-tetrahhydrocarbazole (frovatriptan) et ses sels solvates et hydrates

Country Status (34)

Country Link
US (2) US5464864A (en, 2012)
EP (1) EP0591280B1 (en, 2012)
JP (1) JP3261502B2 (en, 2012)
KR (1) KR100251571B1 (en, 2012)
CN (1) CN1034072C (en, 2012)
AP (1) AP344A (en, 2012)
AT (1) ATE170746T1 (en, 2012)
BR (2) BR9206237A (en, 2012)
CA (1) CA2113726C (en, 2012)
CZ (3) CZ150596A3 (en, 2012)
DE (2) DE10299042I2 (en, 2012)
DK (1) DK0591280T3 (en, 2012)
FI (1) FI103967B (en, 2012)
GB (1) GB9113802D0 (en, 2012)
HU (1) HU218907B (en, 2012)
IE (1) IE922062A1 (en, 2012)
IL (4) IL117104A (en, 2012)
LU (1) LU90939I2 (en, 2012)
MA (1) MA22563A1 (en, 2012)
MX (1) MX9203444A (en, 2012)
NL (1) NL300103I2 (en, 2012)
NO (2) NO304774B1 (en, 2012)
NZ (1) NZ243288A (en, 2012)
PL (3) PL169392B1 (en, 2012)
PT (1) PT100620B (en, 2012)
RU (1) RU2137474C1 (en, 2012)
SA (1) SA92130141B1 (en, 2012)
SG (1) SG47877A1 (en, 2012)
SI (1) SI9200125B (en, 2012)
SK (3) SK280906B6 (en, 2012)
TW (1) TW214544B (en, 2012)
UA (1) UA41254C2 (en, 2012)
WO (1) WO1993000086A1 (en, 2012)
ZA (1) ZA924658B (en, 2012)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9211277D0 (en) 1992-05-28 1992-07-15 Glaxo Group Inc Pharmaceutical compositions
GB9226530D0 (en) * 1992-12-21 1993-02-17 Smithkline Beecham Plc Compounds
GB9226566D0 (en) * 1992-12-21 1993-02-17 Smithkline Beecham Plc Compounds
US5616603A (en) * 1995-05-26 1997-04-01 Smithkline Beecham Plc Enantiomers of carbazole derivatives as 5-HT1 -like agonists
US5618948A (en) * 1995-05-26 1997-04-08 Smithkline Beecham P.L.C. Process for preparing an enantiomer of a carbazole derivative
ES2151993T3 (es) * 1995-06-23 2001-01-16 Lilly Co Eli 1,2,3,4-tetrahidro-9h-carbazoles 6-sustituidos y 10h-ciclohepta(7,6-b)indoles 7-sustituidos.
US5917054A (en) * 1995-07-18 1999-06-29 Smithkline Beecham P.L.C. Process for preparing enantiomers of carbazole derivatives as 5-HT1 -like agonists
US5708187A (en) * 1996-06-27 1998-01-13 Eli Lilly And Company 6-substituted-1,2,3,4-tetrahydro-9H-carbazoles and 7-substituted-10H-cyclohepta 7,6-B!indoles: New 5-HT1F agonists
US5891885A (en) * 1996-10-09 1999-04-06 Algos Pharmaceutical Corporation Method for treating migraine
GB9723061D0 (en) * 1997-10-31 1998-01-07 Vanguard Medica Ltd Medicaments
US6066092A (en) * 1997-11-06 2000-05-23 Cady; Roger K. Preemptive prophylaxis of migraine device and method
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
GB9808069D0 (en) * 1998-04-16 1998-06-17 Vanguard Medica Ltd Novel processes
GB9817911D0 (en) * 1998-08-17 1998-10-14 Vanguard Medica Ltd New use
US20030198669A1 (en) * 2001-07-05 2003-10-23 R.T. Alamo Ventures I, Llc Compositions and methods for rapid dissolving formulations of dihydroergotamine and caffeine for the treatment of migraine
US20030017175A1 (en) * 2001-07-05 2003-01-23 R.T. Alamo Ventures I, Inc. Sublingual administration of dihydroergotamine for the treatment of migraine
US6685951B2 (en) 2001-07-05 2004-02-03 R. T. Alamo Ventures I, Inc. Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine
MXPA04002826A (es) * 2001-09-28 2004-07-02 Hoffmann La Roche Formas pseudopolimorficas de carvedilol.
WO2004000849A2 (en) 2002-06-21 2003-12-31 Suven Life Sciences Limited Tetracyclic arylsulfonyl indoles having serotonin receptor affinity
MXPA04012834A (es) 2002-06-21 2005-04-25 Suven Life Sciences Ltd Arilalquil indoles novedosos que tienen afinidad por el receptor de la serotonina, utiles como agentes terapeuticos, proceso para su preparacion y composiciones farmaceuticas que los contienen.
AU2003285759B2 (en) 2002-11-28 2010-01-28 Suven Life Sciences Limited N-arylsulfonyl-3-aminoalkoxyindoles
US7875605B2 (en) 2002-11-28 2011-01-25 Suven Life Sciences Limited N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them
NZ540841A (en) 2002-12-18 2008-08-29 Suven Life Sciences Ltd Tetracyclic 3-substituted indoles having serotonin receptor affinity
RU2430088C2 (ru) * 2004-07-14 2011-09-27 Центарис Гмбх Производные тетрагидрокарбазола и фармацевтическая композиция на их основе
US7601856B2 (en) 2006-07-27 2009-10-13 Wyeth Benzofurans as potassium ion channel modulators
EP2316824A1 (en) * 2006-08-07 2011-05-04 Actelion Pharmaceuticals Ltd. (3-Amino-1,2,3,4-tetrahydro-9H-carbazoI-9-yl)-acetic acid derivates
JP2010522135A (ja) 2006-10-09 2010-07-01 チャールストン ラボラトリーズ，インコーポレイテッド 医薬組成物
WO2008097664A1 (en) 2007-02-11 2008-08-14 Map Pharmaceuticals, Inc. Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile
US20090069399A1 (en) * 2007-09-12 2009-03-12 Protia, Llc Deuterium-enriched frovatriptan
CA2905541C (en) 2008-01-09 2020-02-11 Charleston Laboratories, Inc. Pharmaceutical compositions comprising an antiemetic and an opioid analgesic
WO2010073253A1 (en) * 2008-12-22 2010-07-01 Natco Pharma Limited Method for preparing an optically active frovatriptan
CA2767576C (en) 2009-07-08 2020-03-10 Charleston Laboratories Inc. Pharmaceutical compositions comprising an antiemetic and an opioid analgesic
US10098674B2 (en) 2009-10-22 2018-10-16 Nuvasive, Inc. System and method for posterior cervical fusion
WO2011050140A1 (en) 2009-10-22 2011-04-28 Blue Fury Consulting, L.L.C. Posterior cervical fusion system and techniques
EP3628325A1 (en) 2011-07-22 2020-04-01 The University of Chicago Treatments for migraine and related disorders
US9394314B2 (en) 2012-12-21 2016-07-19 Map Pharmaceuticals, Inc. 8′-hydroxy-dihydroergotamine compounds and compositions
EP2816030A1 (en) 2013-06-20 2014-12-24 Duke Chem, S. A. Process for the preparation of frovatriptan and its enantiomer
GB201312768D0 (en) 2013-07-17 2013-08-28 Ge Healthcare Ltd Work-up procedure
US10179109B2 (en) 2016-03-04 2019-01-15 Charleston Laboratories, Inc. Pharmaceutical compositions comprising 5HT receptor agonist and antiemetic particulates
EP3766483A1 (en) 2019-07-19 2021-01-20 BioPharma Synergies, S. L. Orodispersible powder composition comprising a triptan
WO2025038666A2 (en) * 2023-08-13 2025-02-20 GATC Health Corp Compounds and methods for treating addiction
CN119499195A (zh) * 2024-11-26 2025-02-25 青岛国信制药有限公司 一种快速吸收琥珀酸呋罗曲坦片及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3642816A (en) * 1967-08-10 1972-02-15 Sterling Drug Inc 3-acetamido-1 2 3 4-tetrahydrocarbazole
US4062864A (en) * 1968-01-24 1977-12-13 Sterling Drug Inc. 3-Hydroxy carbazole derivatives
US3959309A (en) 1968-01-24 1976-05-25 Sterling Drug Inc. 3-Amido-1,2,3,4-tetrahydrocarbazoles
US3592824A (en) * 1970-03-12 1971-07-13 Miles Lab 3-substituted amino-1,2,3,4-tetrahydrocarbazoles
BE787537A (fr) * 1971-08-16 1973-02-14 Sterling Drug Inc Tetrahydrocarbazoles
US4172834A (en) * 1971-08-16 1979-10-30 Sterling Drug Inc. 3-Amino-tetrahydrocarbazoles
DE2815926A1 (de) * 1978-04-13 1979-10-18 Boehringer Mannheim Gmbh Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US4257952A (en) * 1977-06-06 1981-03-24 Sterling Drug Inc. 3-Amino-tetrahydrocarbazoles
US4254134A (en) * 1978-03-17 1981-03-03 Endo Laboratories, Inc. Antidepressant 2-amino- and -2-(substituted amino)-cis-hexahydro-carbazoles
EP0115607A1 (de) * 1983-01-04 1984-08-15 MERCK PATENT GmbH Tetrahydrocarbazolderivate

Also Published As

Publication number Publication date
DE69226953D1 (de) 1998-10-15
JPH06508827A (ja) 1994-10-06
UA41254C2 (uk) 2001-09-17
WO1993000086A1 (en) 1993-01-07
SA92130141B1 (ar) 2005-12-18
IL117105A0 (en) 1996-06-18
NO934800D0 (no) 1993-12-23
DE69226953T2 (de) 1999-05-12
CZ286193A3 (en) 1994-07-13
FI103967B1 (fi) 1999-10-29
NO304774B1 (no) 1999-02-15
GB9113802D0 (en) 1991-08-14
CN1069726A (zh) 1993-03-10
ZA924658B (en) 1993-12-24
CZ282083B6 (cs) 1997-05-14
IL117104A (en) 1997-09-30
SK131993A3 (en) 1994-06-08
NO934800L (no) 1993-12-23
SK280906B6 (sk) 2000-09-12
PL169410B1 (pl) 1996-07-31
PL171034B1 (en) 1997-02-28
DK0591280T3 (da) 1999-02-15
PT100620A (pt) 1993-09-30
CA2113726A1 (en) 1993-01-07
IL117104A0 (en) 1996-06-18
IL117105A (en) 1998-01-04
CZ282061B6 (cs) 1997-05-14
AU652842B2 (en) 1994-09-08
HU218907B (hu) 2000-12-28
CN1034072C (zh) 1997-02-19
AP9200403A0 (en) 1992-07-31
SK280907B6 (sk) 2000-09-12
NO2005011I2 (no) 2008-02-11
SG47877A1 (en) 1998-04-17
FI935842A7 (fi) 1993-12-23
NL300103I1 (nl) 2002-12-02
HK1014669A1 (en) 1999-09-30
KR100251571B1 (ko) 2000-07-01
TW214544B (en, 2012) 1993-10-11
BR9206237A (pt) 1995-04-11
AU1977592A (en) 1993-01-25
PT100620B (pt) 1999-01-29
JP3261502B2 (ja) 2002-03-04
DE10299042I2 (de) 2005-02-03
IL102322A0 (en) 1993-01-14
HUT68961A (en) 1995-08-28
US5637611A (en) 1997-06-10
ATE170746T1 (de) 1998-09-15
EP0591280B1 (en) 1998-09-09
NO2005011I1 (no) 2005-05-18
FI935842A0 (fi) 1993-12-23
AP344A (en) 1994-07-05
PL169392B1 (pl) 1996-07-31
CA2113726C (en) 2008-02-19
BR1100460A (pt) 2000-07-18
IL102322A (en) 1997-09-30
SK280905B6 (sk) 2000-09-12
SI9200125A (en) 1992-12-31
CZ150596A3 (en) 1997-05-14
NZ243288A (en) 1994-09-27
DE10299042I1 (de) 2003-02-20
US5464864A (en) 1995-11-07
SI9200125B (en) 2001-12-31
RU2137474C1 (ru) 1999-09-20
FI103967B (fi) 1999-10-29
MX9203444A (es) 1993-12-01
CZ150696A3 (en) 1997-06-11
IE922062A1 (en) 1992-12-30
NL300103I2 (nl) 2003-02-03
MA22563A1 (fr) 1992-12-31
EP0591280A1 (en) 1994-04-13
CZ282327B6 (cs) 1997-06-11

Similar Documents

Publication Publication Date Title
LU90939I2 (fr) 3-Methtylamino-6carboxamido-1,2,3,4-tetrahhydrocarbazole (frovatriptan) et ses sels solvates et hydrates
GB2256295B (en) Data storage and apparatus
ZA929700B (en) Piperidinyl and pieraziny alkyl indolones.
EP0438961A3 (en) Hardware data string operation controller
GB2254469B (en) Data storage
EP0457563A3 (en) Slant rig cementing apparatus
DE69212210D1 (de) Sicherheitstrokar
GB9018928D0 (en) Laptop computer
EP0548928A3 (en) Portable computer
EP0542430A3 (en) Information access apparatus and methods
EP0596636A3 (en) Cache tag memory
EP0465894A3 (en) Drilling device
SG43849A1 (en) Memory mapped keyboard controller
EP0520707A3 (en) Data storage apparatus
GB9111730D0 (en) Portable drilling apparatus
NO921851L (no) "navlestreng"-frigjoeringsmekanisme
EP0435252A3 (en) Memory access methods and apparatus
EP0488366A3 (en) Data storage apparatus
EP0517162A3 (en) Boring and mortising device
AU115858S (en) Portable Computer
GB2262633B (en) Security of stored data
GB2257194B (en) Computer security
GB9218156D0 (en) Improved drilling apparatus
GB2262443B (en) Wall marking device
GB9021997D0 (en) Bit stuffing apparatus